Skip to main content
Premium Trial:

Request an Annual Quote

NIH Awards $18M in High-End Instrumentation Grants for Biomedical Research

NEW YORK, July 12 (GenomeWeb News) - The National Center for Research Resources of the National Institutes of Health announced today that it has awarded 11 grants worth nearly $18 million to US research institutions to support the acquisition of "high-end instrumentation" for biomedical research.


The one-time grants support the purchase of instruments that cost more than $750,000, with a maximum of $2 million each, NCRR said. In addition, institutions were to identify three or more NIH-funded investigators whose research requires use of the instrument.


Instruments to be purchased using the grants include structural and functional imaging systems, macromolecular NMR spectrometers, high-resolution mass spectrometers, electron microscopes, and supercomputers. The awards include:


·         $2 million to Cold Spring Harbor Laboratory for the purchase of a high-performance computing cluster to "improve and expand the computing infrastructure to support current and new research" using microarrays and comparative bioinformatics;

·         $758,000 to the University of California, San Diego, for the purchase of a MALDI TOF-TOF mass spectrometer;

·         $919,000 to the University of Cincinnati for the acquisition of an ion trap-Fourier transform ion cyclotron resonance hybrid mass spectrometer;

·         $1 million to the University of North Carolina, Chapel Hill, for the purchase of a Fourier-transform ion cyclotron resonance mass spectrometer.


The full list of award recipients, instruments and associated projects can be seen here.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.